{"id":"https://openalex.org/W7214929489","doi":"https://doi.org/10.1136/bmjopen-2026-117523","title":"Temporal trends and regional disparities in costs and affordability of non-insulin antidiabetic drugs in China, 2015\u20132022: a retrospective observational study","display_name":"Temporal trends and regional disparities in costs and affordability of non-insulin antidiabetic drugs in China, 2015\u20132022: a retrospective observational study","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7214929489","doi":"https://doi.org/10.1136/bmjopen-2026-117523","pmid":"https://pubmed.ncbi.nlm.nih.gov/42816084","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13630034"},"language":"en","primary_location":{"id":"doi:10.1136/bmjopen-2026-117523","doi":"https://doi.org/10.1136/bmjopen-2026-117523","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2026-117523","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/16/9/e117523.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopen.bmj.com/content/bmjopen/16/9/e117523.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100644710","display_name":"Xingchen Liu","orcid":"https://orcid.org/0000-0002-5638-4053","observed_orcids":["https://orcid.org/0000-0002-5638-4053"]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingchen Liu","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031666945","display_name":"Fengping Lei","orcid":"https://orcid.org/0009-0005-2133-9462","observed_orcids":["https://orcid.org/0009-0005-2133-9462"]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fengping Lei","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","Xi\u2019an Aerospace Hospital, Xi\u2019an, Shaanxi, China"],"raw_orcid":"https://orcid.org/0009-0005-2133-9462","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]},{"raw_affiliation_string":"Xi\u2019an Aerospace Hospital, Xi\u2019an, Shaanxi, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030067208","display_name":"Sundus Shukar","orcid":"https://orcid.org/0000-0001-8078-165X","observed_orcids":["https://orcid.org/0000-0001-8078-165X"]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Sundus Shukar","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146753351","display_name":"Xingyu Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingyu Liu","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130384722","display_name":"Haoqi Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haoqi Wei","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153637425","display_name":"Chen Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chen Chen","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026661804","display_name":"Ali Hassan Gillani","orcid":"https://orcid.org/0000-0002-8628-9030","observed_orcids":["https://orcid.org/0000-0002-8628-9030"]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Fang","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":"https://orcid.org/0000-0002-8628-9030","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101501589","display_name":"Caijun Yang","orcid":"https://orcid.org/0000-0001-5127-7075","observed_orcids":["https://orcid.org/0000-0001-5127-7075","https://orcid.org/0000-0001-6615-5425"]},"institutions":[{"id":"https://openalex.org/I87445476","display_name":"Xi'an Jiaotong University","ror":"https://ror.org/017zhmm22","country_code":"CN","type":"education","lineage":["https://openalex.org/I87445476"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Caijun Yang","raw_affiliation_strings":["Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China"],"raw_orcid":"https://orcid.org/0000-0001-6615-5425","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Administration, Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi, China","institution_ids":["https://openalex.org/I87445476"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101501589"],"corresponding_institution_ids":["https://openalex.org/I87445476"],"apc_list":{"value":1500,"currency":"GBP","value_usd":1839},"apc_paid":{"value":1500,"currency":"GBP","value_usd":1839},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.67885932,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"9","first_page":"e117523","last_page":"e117523"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-insulin-antidiabetic-drugs","display_name":"non-insulin antidiabetic drugs","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-affordability","display_name":"drug affordability","score":0.7210000157356262},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.7089999914169312},{"id":"https://openalex.org/keywords/temporal-trends","display_name":"temporal trends","score":0.7490000128746033},{"id":"https://openalex.org/keywords/regional-disparities","display_name":"regional disparities","score":0.9959999918937683},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.37299999594688416},{"id":"https://openalex.org/keywords/biguanides","display_name":"biguanides","score":0.8169999718666077},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":1.0},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.7570000290870667},{"id":"https://openalex.org/keywords/equitable-access-to-medicines","display_name":"equitable access to medicines","score":0.6520000100135803},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.9599999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.906499981880188},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.786899983882904},{"id":"https://openalex.org/C107029721","wikidata":"https://www.wikidata.org/wiki/Q19188","display_name":"Mainland China","level":3,"score":0.5328999757766724},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.5083000063896179},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.46219998598098755},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4544000029563904},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.3652999997138977},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.3650999963283539},{"id":"https://openalex.org/C201650216","wikidata":"https://www.wikidata.org/wiki/Q829492","display_name":"Procurement","level":2,"score":0.34929999709129333},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.3188999891281128},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31200000643730164},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.29989999532699585},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.2978000044822693},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.2644999921321869},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.2639000117778778},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.262800008058548},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.26170000433921814},{"id":"https://openalex.org/C25511272","wikidata":"https://www.wikidata.org/wiki/Q295136","display_name":"Ecological study","level":3,"score":0.25529998540878296},{"id":"https://openalex.org/C145097563","wikidata":"https://www.wikidata.org/wiki/Q1148747","display_name":"Payment","level":2,"score":0.25529998540878296},{"id":"https://openalex.org/C145096142","wikidata":"https://www.wikidata.org/wiki/Q5333450","display_name":"Economic cost","level":2,"score":0.25049999356269836},{"id":"https://openalex.org/C2781300146","wikidata":"https://www.wikidata.org/wiki/Q1140140","display_name":"Mainland","level":2,"score":0.25040000677108765},{"id":"https://openalex.org/C47344431","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health policy","level":3,"score":0.25029999017715454}],"mesh":[{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1136/bmjopen-2026-117523","doi":"https://doi.org/10.1136/bmjopen-2026-117523","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2026-117523","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/16/9/e117523.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},{"id":"pmid:42816084","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42816084","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13630034","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13630034/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:ec7ed02d387547f3b9933d1512580950","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ec7ed02d387547f3b9933d1512580950","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open, Vol 16, Iss 9 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/bmjopen-2026-117523","doi":"https://doi.org/10.1136/bmjopen-2026-117523","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2026-117523","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/16/9/e117523.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"},{"id":"https://metadata.un.org/sdg/10","score":0.7307999730110168,"display_name":"Reduced inequalities"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5230200521","display_name":null,"funder_award_id":"72174166","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214929489.pdf","grobid_xml":"https://content.openalex.org/works/W7214929489.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2904963605","https://openalex.org/W2981064451","https://openalex.org/W3114719742","https://openalex.org/W4285739918","https://openalex.org/W4377564219","https://openalex.org/W4384655740","https://openalex.org/W4390952174","https://openalex.org/W4391773457","https://openalex.org/W4393861088","https://openalex.org/W4394957664","https://openalex.org/W4404956878","https://openalex.org/W4409205238","https://openalex.org/W4411995056"],"related_works":["https://openalex.org/W7163348752","https://openalex.org/W4394813349","https://openalex.org/W4393861088","https://openalex.org/W2890430196","https://openalex.org/W4415748394","https://openalex.org/W7166809020","https://openalex.org/W2980451819","https://openalex.org/W4402783590","https://openalex.org/W4401272653","https://openalex.org/W3193224802"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"assess":[2],"temporal":[3,127],"trends":[4],"and":[5,11,21,83,93,106,131,138,155,197,234,239,249,253,269,284,296],"regional":[6,94],"disparities":[7,217,264],"in":[8,17,38,129,153,160,223,230,236,259,293],"the":[9,79,91,111,114,119,173,183,204,213,220,231,237,251,274],"costs":[10,130,144,295],"affordability":[12,84,107,132,202,214,225,254],"of":[13,53,86,113,151,175,255,277],"non-insulin":[14,62,87,256],"antidiabetic":[15,63,88,257],"drugs":[16,64,89,258],"China":[18,40,260],"between":[19],"2015":[20,42,248],"2022.":[22,44,161],"DESIGN:":[23],"A":[24],"retrospective":[25],"observational":[26],"study":[27,184,221],"using":[28,102],"monthly":[29,57,143],"provincial":[30],"procurement":[31,58],"data.":[32],"SETTING:":[33],"27":[34],"provincial-level":[35],"administrative":[36],"regions":[37],"mainland":[39],"from":[41,168],"to":[43,118,158,170,281],"PARTICIPANTS:":[45],"No":[46],"individual":[47],"participants":[48],"were":[49,55,78],"included.":[50],"The":[51,75,96],"units":[52],"analysis":[54],"aggregated":[56],"records":[59],"for":[60,289],"29":[61],"classified":[65],"into":[66],"nine":[67],"therapeutic":[68,134,166,191,267],"categories.":[69,192],"PRIMARY":[70],"AND":[71],"SECONDARY":[72],"OUTCOME":[73],"MEASURES:":[74],"primary":[76],"outcomes":[77,125],"30-day":[80,97,115],"treatment":[81,98,116],"cost":[82,99,117,252],"ratio":[85,112],"at":[90,203],"national":[92],"levels.":[95],"was":[100,108,226],"calculated":[101],"defined":[103],"daily":[104,122],"doses":[105],"assessed":[109],"as":[110],"corresponding":[120],"minimum":[121],"wage.":[123],"Secondary":[124],"included":[126],"changes":[128,292],"by":[133],"category,":[135],"active":[136],"ingredient":[137],"region.":[139],"RESULTS:":[140],"National":[141],"average":[142],"fluctuated":[145],"before":[146],"2019,":[147],"reaching":[148],"a":[149,286],"peak":[150],"US$18.53":[152],"2019":[154,169],"subsequently":[156],"declined":[157,163],"US$11.34":[159],"Costs":[162],"across":[164,190,266],"all":[165],"categories":[167,210,268],"2022,":[171,194,224,250],"although":[172],"magnitude":[174],"reduction":[176],"varied":[177],"considerably.":[178],"Affordability":[179],"also":[180],"improved":[181,261],"over":[182],"period,":[185],"but":[186,263],"substantial":[187],"differences":[188],"remained":[189,211],"By":[193],"only":[195],"biguanides":[196],"sulfonylureas":[198],"had":[199],"achieved":[200,242],"good":[201,244],"category":[205],"level,":[206],"while":[207],"several":[208],"other":[209],"above":[212],"threshold.":[215],"Regional":[216],"persisted":[218,265],"throughout":[219],"period;":[222],"relatively":[227],"more":[228],"favourable":[229],"central":[232],"region":[233,241],"poorer":[235],"northwest,":[238],"no":[240],"overall":[243],"affordability.":[245,297],"CONCLUSIONS:":[246],"Between":[247],"overall,":[262],"regions.":[270],"These":[271],"findings":[272],"highlight":[273],"continuing":[275],"challenge":[276],"ensuring":[278],"equitable":[279],"access":[280],"higher-cost":[282],"therapies":[283],"provide":[285],"historical":[287],"benchmark":[288],"evaluating":[290],"subsequent":[291],"drug":[294]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-01T00:00:00"}